Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

biomarkers

  • You have access
    Tissue Expression and Prognostic Role of CXCL12 and CXCR4 in High-grade Serous Ovarian Carcinoma
    HYUNJI LIM, SE IK KIM, EUN NA KIM, MARIA LEE, CHEOL LEE, JAE-WEON KIM and HYUN HOON CHUNG
    Anticancer Research July 2023, 43 (7) 3331-3340; DOI: https://doi.org/10.21873/anticanres.16509
  • Open Access
    The Role of Genetic Polymorphisms in the Diagnosis and Management of Prostate Cancer: An Update
    LUCIO DELL’ATTI and GIANLUCA AGUIARI
    Anticancer Research January 2023, 43 (1) 317-322; DOI: https://doi.org/10.21873/anticanres.16166
  • Open Access
    Integrin Expression in Localized Prostate Cancer: A TCGA and MSKCC Cohort-based Exploratory In Silico Analysis
    MANUEL NEUBERGER, LISA FREY, KATJA NITSCHKE, FREDERIK WESSELS, NIKLAS WESTHOFF, FRANK WALDBILLIG, MALIN NIENTIEDT, FRIEDRICH HARTUNG, JOST VON HARDENBERG, MAURICE STEPHAN MICHEL, PHILIPP ERBEN, PHILIPP NUHN and THOMAS STEFAN WORST
    Anticancer Research January 2023, 43 (1) 417-428; DOI: https://doi.org/10.21873/anticanres.16177
  • You have access
    Baseline Modified Glasgow Prognostic Score (mGPS) Predicts Radiologic Response and Overall Survival in Metastatic Hormone-sensitive Prostate Cancer Treated With Docetaxel Chemotherapy
    MANUEL NEUBERGER, JANINA SKLADNY, NORA GOLY, FREDERIK WESSELS, CHRISTEL WEIß, LUISA EGEN, PHILIPP ERBEN, MATTHIAS GROß-WEEGE, BRITTA GRÜNE, FRIEDRICH HARTUNG, JONAS HERRMANN, PATRICK HONECK, JONAS JARCZYK, KARL-FRIEDRICH KOWALEWSKI, JULIA MÜHLBAUER, KATJA NITSCHKE, MALIN NIENTIEDT, MARGARETE THERESA WALACH, FRANK WALDBILLIG, NIKLAS WESTHOFF, JOST VON HARDENBERG, MAXIMILIAN KRIEGMAIR, THOMAS S. WORST and PHILIPP NUHN
    Anticancer Research April 2022, 42 (4) 1911-1918; DOI: https://doi.org/10.21873/anticanres.15668
  • You have access
    Adjuvant Radiotherapy in Patients With Pancreatic Adenocarcinoma. Is It Still Appealing in Clinical Trials? A Meta-analysis and Review of the Literature
    FRANCESCO PASQUALETTI, ALDO SAINATO, RICCARDO MORGANTI, CONCETTA LALISCIA, ENRICO VASILE, ALESSANDRA GONNELLI, SABRINA MONTRONE, GIOVANNI GADDUCCI, NOEMI GIANNINI, NATALINA COCCIA, TAIUSHA FUENTES, SOFIA ZANOTTI, MASSIMO FALCONI and FABIOLA PAIAR
    Anticancer Research October 2021, 41 (10) 4697-4704; DOI: https://doi.org/10.21873/anticanres.15283
  • You have access
    BAI1 as a Prognostic Marker of Clear Cell Renal Cell Carcinoma (ccRCC)
    MARTIN PESTA, IVAN TRAVNICEK, VLASTIMIL KULDA, JINDRA WINDRICHOVA, HANA REZACKOVA, KATERINA HOUFKOVA, TEREZA MACANOVA, BARBORA BENDOVA, ANDREA NESTOROVA, ONDREJ HES, MILAN HORA, ONDREJ TOPOLCAN and JIRI POLIVKA
    Anticancer Research September 2021, 41 (9) 4463-4470; DOI: https://doi.org/10.21873/anticanres.15255
  • You have access
    Clinically Applicable Serum Biomarkers Among 14 Candidates Associated With Recurrence of Stage II and III Colorectal Cancer
    CHAN WOOK KIM, YE JIN HA, KA HEE TAK, SEON AE ROH, SEON-KYU KIM, SEON-YOUNG KIM, YONG SUNG KIM, DONG-HYUNG CHO and JIN CHEON KIM
    Anticancer Research September 2021, 41 (9) 4651-4658; DOI: https://doi.org/10.21873/anticanres.15279
  • You have access
    Role of Ki-67, MRE11, and PD-L1 as Predictive Biomarkers for Recurrence Pattern in Muscle-invasive Bladder Cancer
    CROIX C. FOSSUM, YIN XIONG, ANTHONY MAGLIOCCO, SIAMAK DANESHMAND, MANJU ARON, KENT W. MOUW, ZARKO MANOJLOVIC, SUSAN MCCARTHY, CHRISTINA PHUONG, TANYA DORFF, SUMEET K. BHANVADIA and LESLIE K. BALLAS
    Anticancer Research August 2021, 41 (8) 3851-3857; DOI: https://doi.org/10.21873/anticanres.15178
  • You have access
    Independent Validation of a Comprehensive Machine Learning Approach Predicting Survival After Radiotherapy for Bone Metastases
    CARSTEN NIEDER, BÅRD MANNSÅKER and ROSALBA YOBUTA
    Anticancer Research March 2021, 41 (3) 1471-1474; DOI: https://doi.org/10.21873/anticanres.14905
  • You have access
    Neurological Death After Radiotherapy for Brain Metastases: Role of the LabBM Score
    CARSTEN NIEDER, BÅRD MANNSÅKER and ROSALBA YOBUTA
    Anticancer Research January 2021, 41 (1) 341-345; DOI: https://doi.org/10.21873/anticanres.14781

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire